On June the 4th I reported on the SWOG-9346 study presented at the ASCO Meeting in Chicago (http://advancedprostatecancer.net/?p=3264). In the presentation by principal investigator, Maha Hussain, M.D., F.A.C.P., from the University of Michigan Comprehensive Cancer Center, Dr. Hussain reported that intermittent androgen-deprivation (IAD) therapy for men with advanced prostate cancer with bone metastasis is not as good as continuous hormone therapy with regard to a man’s longevity!

After having thought about the startling conclusions of the phase III study I wrote an additional post about my personal decision to continue current plans to remain on intermittent hormone therapy.

My Current Personal Take on Intermittent Hormone Therapy for Prostate Cancer
http://advancedprostatecancer.net/?p=3274

Today, Dr. S Meyers posted a video discussing this very same topic. Dr. Meyer’s conclusions were consistent with mine, but of course he is much more eloquent then I am capable of being.

I highly recommend that you watch the video, which can be seen at:
http://tinyurl.com/6ucf6x9

It is very comforting to see that he has drawn the same conclusion that I have; I continue to plan on remaining on an intermittent hormone therapy schedule.

Joel T. Nowak, M.A., M.S.W.